This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eskes, R.
Right arrow Articles by Martinou, J.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eskes, R.
Right arrow Articles by Martinou, J.-C.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, February 2000, p. 929-935, Vol. 20, No. 3
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Bid Induces the Oligomerization and Insertion of Bax into the Outer Mitochondrial Membrane

Robert Eskes,dagger Solange Desagher, Bruno Antonsson, and Jean-Claude Martinou*

Serono Pharmaceutical Research Institute, Ares Serono International S.A., CH-1228 Plan-les Ouates, Geneva, Switzerland

Received 21 June 1999/Returned for modification 9 August 1999/Accepted 25 October 1999


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In many types of apoptosis, the proapoptotic protein Bax undergoes a change in conformation at the level of the mitochondria. This event always precedes the release of mitochondrial cytochrome c, which, in the cytosol, activates caspases through binding to Apaf-1. The mechanisms by which Bax triggers cytochrome c release are unknown. Here we show that following binding to the BH3-domain-only proapoptotic protein Bid, Bax oligomerizes and then integrates in the outer mitochondrial membrane, where it triggers cytochrome c release. Bax mitochondrial membrane insertion triggered by Bid may represent a key step in pathways leading to apoptosis.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Bcl-2 family members play a key role in processes underlying programmed cell death or apoptosis (17, 25, 36). The Bcl-2 family is composed of both antiapoptotic (Bcl-2, Bcl-xL, Bcl-w, Mcl-1, A1, NR-13, BHRF1, LMW5-HL, ORF16, KS-Bcl-2, E1B-19K, and CED-9) and proapoptotic (Bax, Bak, Bok, Bik, Blk, Hrk, BNIP3, BimL, Bad, Bid, and EGL-1) molecules (1). These proteins can form homo- and heterodimers that involve amino acid sequences known as Bcl-2 homology (BH) domains. Four of these domains (BH1 to BH4) have been identified (20, 25, 36, 44). The BH3 domain of the proapoptotic members appears to be required for the interaction between anti- and proapoptotic molecules (5).

The principal site of action of some of the Bcl-2 family members appears to be the mitochondrion (9, 19, 21, 37, 41). Mitochondria play a major role in many types of apoptosis. In particular, this organelle releases apoptosis-inducing factor (40) and cytochrome c (3, 9, 19, 21, 37, 45). The latter triggers caspase 9 activation through Apaf-1-caspase 9 complex formation (26). Bcl-2 family members play a key role in regulating cytochrome c release. While Bcl-2 and Bcl-xL suppress cytochrome c release (3, 21, 45), Bax stimulates this event both in vitro in isolated mitochondria and in intact cells following heterologous expression (3, 9, 19). The mechanisms by which these proteins perform their function are currently unknown.

The three-dimensional structures of Bcl-xL (34) and Bid (6, 31) revealed structural similarities between these proteins and the channel-forming domains of the bacterial toxins colicins and diphtheria toxins. Consistent with such structural similarity, some members of this family including Bax, Bcl-2, and Bcl-xL are also able to form ion channels in synthetic lipid membranes (2, 33, 38, 39). The channel-forming activity of these proteins has not yet been demonstrated in vivo. However, it is now clear that, at least during apoptosis, these proteins are associated with intracellular membranes, in particular with mitochondrial membranes. The events that trigger membrane association of the Bcl-2 family members are still poorly understood, although it is probable that, like colicins and diphtheria toxins, Bcl-2 family members may have to undergo a change in conformation before undertaking membrane insertion.

We have previously shown that at an early stage of apoptosis in cerebellar granule cells deprived of serum and potassium or in HeLa cells exposed to staurosporine, Bax undergoes a change in conformation (8). Similarly, the structure of Bak, another proapoptotic member of the Bcl-2 family, was reported to undergo conformational change during various types of apoptosis well before cytochrome c release from mitochondria (8, 12). For both Bax and Bak, this change in conformation appears to expose the N-terminal domain, which otherwise is cryptic and nonaccessible to antibodies. Interestingly, Bid, a BH3-domain-only protein which interacts with Bax, was able to trigger this conformational change in Bax (8). The goal of our present experiments was to understand the role of the switch in Bax conformation and how this key event could be related to cytochrome c release from mitochondria. Here we report that following Bid-induced conformational change, Bax oligomerizes and inserts tightly within the outer mitochondrial membrane without a requirement for any proteolytic event. The integration of Bax in the outer mitochondrial membrane is followed by cytochrome c release, which, in contrast to Bax membrane integration, is highly dependent on magnesium.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cell culture. HeLa cells and the stable HeLa cell line that constitutively overexpresses Bcl-2 (HeLa-Bcl-2) (10) were cultured in a 1:1 mixture of basal Iscove medium and Ham's F-12 medium (Seromed) supplemented with 10% fetal calf serum and 2 mM L-glutamine.

Subcellular fractionation. At different times after the induction of apoptosis, HeLa cells were harvested in isotonic mitochondrial buffer (MB) (210 mM mannitol, 70 mM sucrose, 1 mM EDTA, 10 mM HEPES [pH 7.5]) supplemented with complete protease inhibitor cocktail (Boehringer Mannheim). The cells were broken by six passages through a 25G1 0.5- by 25-mm needle fitted on a 5-ml syringe, and the suspension was centrifuged at 2,000 × g in an Eppendorf centrifuge at 4°C. This procedure was repeated twice, and supernatants from each step were pooled before being subjected to centrifugation at 13,000 × g at 4°C for 10 min. The supernatant was further centrifuged at 600,000 × g for 10 min at 4°C to yield the light membrane pellet (not analyzed) and the final soluble fraction (S100). The heavy membrane material was pooled and resuspended in MB-EGTA (MB with 0.5 mM EGTA instead of EDTA) and centrifuged at 500 × g for 3 min at 4°C to eliminate residual nuclei. The resulting supernatant was centrifuged at 10,000 × g for 10 min at 4°C to further purify the mitochondrial fraction. The protein concentration was estimated by the method of Bradford (4) with bovine serum albumin as the standard.

In vitro assay for Bax insertion and cytochrome c release. Mitochondria (100 µg of proteins) were incubated in the presence or absence of various recombinant proteins in 100 µl of MBC buffer (MB with EGTA supplemented with 4 mM MgCl2, 5 mM Na2HPO4, 5 mM succinate, and 5 µM rotenone) for 15 min at 30°C and then centrifuged for 5 min at 13,000 × g and 4°C. The supernatants and the pellets were used for the determination of cytochrome c release. For alkali extraction, the mitochondrial pellets were resuspended (1 mg of protein/ml) in freshly prepared 0.1 M Na2CO3 (pH 11.5) and incubated for 20 min on ice. The membranes were then pelleted by centrifugation (600,000 × g for 20 min at 4°C). Mitochondrial membrane pellets corresponding to 10 µg of proteins (the alkali-resistant fractions) and the corresponding volume of supernatants (the alkali-sensitive fractions) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis on 4 to 20% Tris-Gly gels (NOVEX). Their respective contents of cytochrome c and Bax were estimated by Western blotting with a polyclonal anti-cytochrome c antibody (dilution 1:2,500) or a polyclonal antibody directed against Bax (Upstate Biotechnology). Equal loading of the mitochondrial pellet was verified by using an antibody either against cytochrome c oxidase subunit IV (Cox IV) or against cytochrome c oxidase subunit II (Cox II) (both from Molecular Probes) or an antibody against the voltage-dependent anion channel VDAC (Calbiochem). Antigen-antibody complexes were detected by using horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G and enhanced chemiluminescence detection reagents.

Cross-linking. The mitochondria (0.5 mg of proteins) were incubated with the recombinant proteins, then pelleted by centrifugation, and resuspended in MB-EGTA, and disuccinimidyl subernate (DSS) (in dimethyl sulfoxide DMSO; Pierce) or bis(sulfosuccinimidyl) subernate (BS3) (in 5 mM sodium citrate buffer [pH 5.0]; Pierce) was added from a 10-fold stock solution to a final concentration of 2 mM. After incubation for 30 min at room temperature, the cross-linker was quenched by the addition of 1 M Tris-HCl (pH 7.5) to a final concentration of 20 mM. After quenching, the membranes were dissolved in RIPA buffer and cleared by centrifugation at 12,000 × g. The lysate was immunoprecipitated with anti-Bax 2D2 monoclonal antibody (Genzyme) and then analyzed by Western blotting with the polyclonal anti-Bax antibody.

Digitonin treatment of mitochondria. Following incubation with Bid, mitochondria (100 µg) were pelleted, dissolved in 100 µl of digitonin (1.2 mg/ml), and incubated for 25 min on ice. The mitoplasts were pelleted by centrifugation and dissolved in 100 µl of RIPA buffer. The fractions were analyzed by Western blotting as mentioned above.

Production of recombinant proteins. His-tagged Bid, Bid mutants, human Bcl-xL, and human mutant Bcl-xL (Bcl-xLm: G138right-arrowA), both Bcl-xL protins lacking 24 amino acids at the COOH terminus, were produced as described previously (8).


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Bax integration into the mitochondrial membrane in staurosporine-treated HeLa cells. In many cultured cells, Bax is found in both the cytosolic and mitochondrial fractions (15, 43; unpublished observation). To test whether mitochondrial Bax was integrated in the mitochondrial membranes, we performed an alkali extraction of proteins from mitochondria isolated from HeLa cells. Bcl-xL, Bak, and Cox II were analyzed in parallel. In contrast to Bcl-xL or Bak, which were resistant to the alkali extraction, most Bax was lost during this treatment, indicating that under normal conditions Bax is loosely attached to mitochondria while most Bcl-xL and Bak proteins are inserted in the membrane (Fig. 1A and B). When HeLa cells were treated with staurosporine, Bax became resistant to alkali extraction in a time-dependent manner. After 12 h of incubation with staurosporine, almost all the Bax was found to be inserted in the mitochondrial membranes (Fig. 1A). These results, in agreement with previous results reported by Goping et al. (11), demonstrate that in response to a death stimulus, Bax becomes inserted in the mitochondrial membranes.


View larger version (34K):
[in this window]
[in a new window]
  		FIG. 1.   Bax integration into the mitochondrial membranes during apoptosis and after Bid treatment. (A) Mitochondria from HeLa cells cultured in the absence or presence of 1 µM staurosporine for increasing times were isolated and treated with 0.1 M Na2CO3 to produce alkali-sensitive (Att [attached]) and -resistant (Ins [inserted]) fractions. Both fractions were analyzed by Western blotting for the presence of Bax. Cox II was used as a gel-loading control. (B) Mitochondria from HeLa cells were incubated with 100 nM recombinant wild-type Bid and two Bid mutants (BidmIII-1 and BidmIII-3) for 15 min at 30°C, recovered by centrifugation, and treated with 0.1 M Na2CO3 as above. Various proteins were analyzed by Western blotting in alkali-sensitive (Att.) and -resistant fractions (Ins.). (C) Cytochrome c was analyzed by Western blotting in the mitochondrial suspension following incubation with wild-type and mutant Bid.

The major objective of this study was to determine the mechanisms that are responsible for Bax insertion in mitochondrial membranes. We reported previously that during staurosporine-triggered apoptosis of HeLa cells, mitochondrial Bax undergoes a change in conformation, rendering its N terminus accessible to antibodies (8). This event was accompanied by a release of cytochrome c. Moreover, we reported that Bid, which translocates to mitochondria during apoptosis, was able to trigger a change in Bax conformation when added directly to isolated mitochondria. Bid was therefore a likely candidate as the protein responsible for driving the Bax integration into the mitochondrial membrane. Figure 1B shows that addition of 100 nM Bid to mitochondria isolated from HeLa cells rendered Bax resistant to alkali extraction, indicating that it had undergone membrane integration. Similar results were obtained when mitochondria were incubated in the presence of 100 nM Bid and 100 µM z-VAD-fmk, a broad-spectrum caspase peptide inhibitor, indicating that Bid-induced Bax membrane insertion was independent of caspase activation (results not shown). The mitochondrial levels of Bcl-xL, Bak, Cox IV, and VDAC, all membrane-integrated proteins, did not change following Bid treatment (Fig. 1B). Bid association with the mitochondria remained sensitive to alkali treatment, suggesting that in contrast to Bax, this protein does not itself integrate into the mitochondrial membranes (Fig. 1B).

Bid interacts with other Bcl-2 family members via its BH3 domain (42). To determine if binding of Bid to Bax is a prerequisite for Bax insertion, two Bid BH3 mutants with selectively lowered affinity for either Bax (BidmIII-3: G94right-arrowA) (8, 42) or Bcl-2 (BidmIII-1: M97D98right-arrowAA) (8, 42) were tested. While BidmIII-1 was as effective as wild-type Bid, BidmIII-3 was unable to stimulate Bax insertion (Fig. 1B) and cytochrome c release from mitochondria (Fig. 1C). Together, these results strongly indicate that Bid induces the insertion of Bax by interacting directly with Bax.

Bax integration in the outer mitochondrial membrane. We next tested whether Bax inserts into the outer or the inner mitochondrial membrane by using digitonin to selectively dissolve the outer mitochondrial membrane. VDAC and Cox IV, which are present in the outer and inner mitochondrial membranes, respectively, were used to set up the conditions for optimal extraction. In the presence of 1.2 mg of digitonin/mg of protein, mitochondria from HeLa cells lost most of the VDAC protein while Cox IV remained attached to the mitochondria, indicating conditions for selective extraction of proteins from the outer mitochondrial membrane (Fig. 2). Like VDAC, Bax was found to be sensitive to digitonin extraction, confirming that in nonapoptotic cells Bax is attached to the outer mitochondrial membrane. A small amount of Bax remained insensitive to digitonin extraction, which could reflect Bax present at contact sites, although we cannot exclude the possibility that a minor portion of the protein is also localized in the inner mitochondrial membrane. Importantly, however, the fraction of digitonin-resistant Bax was unaltered following incubation with Bid for 15 min. In contrast, an increase in the amount of digitonin-sensitive Bax was detected (Fig. 2). The increase in Bax levels detected in the presence of Bid reflects the fact that Bax becomes tightly attached to mitochondrial membranes, while in the absence of Bid, substantial amounts of Bax can be easily lost from mitochondria during repetitive washes. Bcl-xL was also present mainly in the outer mitochondrial membrane, and its distribution remained unchanged following treatment with Bid (Fig. 2). We conclude from these experiments that following its interaction with Bid, Bax integrates into the outer mitochondrial membrane.


View larger version (60K):
[in this window]
[in a new window]
  		FIG. 2.   Bid induces the insertion of Bax into the outer mitochondrial membrane. Isolated mitochondria (100 µg) from HeLa cells were incubated with 100 nM Bid for 15 min at 30°C and treated with digitonin (1.2 mg/ml) for 25 min at 4°C. The digitonin-sensitive (Out. [outer mitochondrial membrane]) and resistant (In. [inner mitochondrial membrane]) fractions were analyzed by Western blotting for the presence of VDAC, Cox IV, Bax, and Bcl-xL.

Bax dimerization. It was reported previously that Bax is present in a monomeric form in the cytoplasm (16) and that dimerization is a prerequisite for mitochondrial translocation (13). This prompted us to test whether Bid was able to trigger Bax dimerization and whether this precedes membrane integration. Intact mitochondria were treated with either the membrane-permeable DSS or the non-membrane-permeable BS3 cross-linking agents. In the absence of Bid, Bax was detected as a monomer. However, in the presence of 100 nM Bid, two Bax-immunoreactive bands of approximately 40 and 60 kDa were clearly detectable (Fig. 3). These are likely to correspond either to Bax homodimers and trimers or to Bax heterodimers. We also detected an additional Bax-immunoreactive band running at ~40 kDa that could correspond to a Bax monomer linked to an unknown protein (Fig. 3). Similar results were obtained with two different anti-Bax antibodies. No immunoreactivity of these protein bands was detected with antibodies directed against Bcl-2, Bcl-xL, Bag-1, Bid, or VDAC.


View larger version (43K):
[in this window]
[in a new window]
  		FIG. 3.   Bid induces Bax oligomerization. Isolated mitochondria from HeLa cells were incubated with 1 µM Bid for 15 min at 30°C, and the mitochondrial pellet was treated with two different cross-linkers as described in Materials and Methods. After cross-linking, the mixture was immunoprecipitated with anti-Bax monoclonal antibody and analyzed by Western blotting with an anti-Bax polyclonal antibody.

We next examined the temporal relationship between Bax oligomerization, its membrane insertion, and mitochondrial cytochrome c release. Figure 4A shows that upon addition of Bid to isolated mitochondria, Bax dimers and trimers were observed within 2.5 to 5 min and their levels peaked at 10 min. Importantly, Bax oligomerization preceded Bax insertion into the membrane, which appeared evident only between 5 and 10 min after Bid addition (Fig. 4B). Release of cytochrome c from mitochondria also occurred between 5 and 10 min after Bid addition, although maximal levels were not observed until after 15 min (Fig. 4C). These results suggest that Bax dimerization (or oligomerization) precedes its membrane integration and the efflux of cytochrome c from mitochondria.


View larger version (41K):
[in this window]
[in a new window]
  		FIG. 4.   Time course study of Bax oligomerization, Bax membrane insertion, and cytochrome c release after addition of Bid to isolated mitochondria. Isolated mitochondria from HeLa cells were incubated with recombinant Bid at 30°C for increasing times and analyzed for Bax oligomerization (A), Bax membrane insertion (B), and cytochrome c release (C). Att., attached (alkali sensitive); Ins., inserted (alkali resistant); Cyt.c, cytochrome c.

Regulation of Bid-induced Bax integration in the outer mitochondrial membrane by Bcl-xL and Bcl-2. We have shown previously that Bcl-2 and Bcl-xL are able to inhibit the change in conformation of Bax in cells exposed to an apoptotic stimulus or following the addition of Bid to isolated mitochondria. Here we tested whether Bcl-xL could prevent Bid-induced Bax oligomerization and insertion into the membrane. We found that in the presence of Bcl-xL, Bid was unable to trigger Bax membrane integration, cytochrome c release, or Bax oligomerization (Fig. 5A to C). In contrast, a mutant of Bcl-xL (Bcl-xLm), which fails to bind Bax, did not inhibit these sequential events. Bid was also unable to trigger Bax integration when added to mitochondria from HeLa cells overexpressing Bcl-2 (Fig. 5D).


View larger version (26K):
[in this window]
[in a new window]
  		FIG. 5.   Bcl-xL and Bcl-2 inhibit Bid-induced oligomerization and insertion of Bax into the outer mitochondrial membrane. (A to C) Mitochondria isolated from HeLa cells were incubated with 100 nM Bid in the presence of 1 µM recombinant Bcl-xL or Bcl-xLm at 30°C for 15 min. Mitochondria were used to study Bax insertion into the outer mitochondrial membrane (A), cytochrome c release (B), and Bax dimerization (C). (D) Mitochondria from HeLa cells overexpressing Bcl-2 were isolated and incubated with 100 nM Bid at 30°C for 15 min and used to analyze Bax insertion into the outer mitochondrial membrane. Att., attached (alkali sensitive); Ins., inserted (alkali resistant); Ctl., Cont., control; Cyt.c, cytochrome c.

Membrane insertion of Bax without cytochrome c release in the absence of magnesium ions. We have reported previously that the ability of Bax to trigger cytochrome c release from mitochondria was highly dependent on magnesium ions but independent of the opening of the permeability transition pore (9). We have now extended these observations by testing whether magnesium is important for membrane insertion of Bax. Figure 6A shows that Bax was resistant to alkali extraction following Bid addition to mitochondria in both the presence and absence of 2.5 mM Mg2+, indicating that Bax integration in the membrane occurs independently of Mg2+. However, only mitochondria incubated with Bid in the presence of 2.5 mM Mg2+ were found to release cytochrome c (Fig. 6B). Similar results were obtained with 2.5 mM MnCl2, which can substitute for MgCl2 in many cases (Fig. 6). However, other ions such as sodium, potassium, or lithium, all tested at 5 mM, were much less effective (Fig. 6B). We conclude that the presence of magnesium is important for Bax-induced cytochrome c release only after Bax is inserted in the mitochondria.


View larger version (27K):
[in this window]
[in a new window]
  		FIG. 6.   In contrast to cytochrome c release, Bid-induced insertion of Bax does not require the presence of Mg2+. (A) Mitochondria from HeLa cells were incubated with 100 nM Bid for 15 min at 30°C in the presence or absence of 2.5 mM MgCl2 or MnCl2 before analysis of Bax insertion into membranes. (B) Mitochondria were incubated in the presence or absence of 100 nM Bid and various salts including MgCl2 (2.5 mM), MnCl2 (2.5 mM), KCl (5 mM), NaCl (5 mM), and LiCl (5 mM). Both supernatants and mitochondrial pellets were analyzed for cytochrome c release. Ctl., control; Att., attached (alkali sensitive); Ins., inserted (alkali resistant); Cyt. c, cytochrome c.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Bax, a proapoptotic protein that is absolutely required for apoptosis in many neuronal cell types and in ovarian follicles (7, 32), exerts at least part of its activity by triggering cytochrome c release from mitochondria (9, 19, 21, 37, 41). The mechanisms by which Bax stimulates cytochrome c efflux are still unclear. In previous reports, several events occurring during apoptosis at the level of the Bax protein, including translocation to mitochondria (15, 43), change in conformation (8), dimerization (11, 13), and membrane integration (11, 13), have been described. Despite this, the mechanisms responsible for Bax insertion into the mitochondrial membrane and the localization of Bax within mitochondria are still unclear. Here we show that Bid, a BH3-only Bax-interacting protein, is able to trigger Bax integration in the outer mitochondrial membrane. We have reported previously that Bid is able to induce a change in Bax conformation leading to the exposure of its N-terminal domain. Interestingly, the N-terminal domain of Bax exerts a repressing activity on the targeting of Bax to mitochondrial membranes, possibly by interfering with the hydrophobic C-terminal membrane-anchoring domain (11). A Bid-induced change in Bax conformation may therefore represent the first of a series of events leading to Bax insertion into membranes. Bax dimerization appears to be another critical event for Bax integration in membranes, since enforced dimers of Bax specifically target mitochondria and trigger some mitochondrial dysfunction (13). However, in this study, the Bax-enforced dimers failed to trigger cytochrome c release from mitochondria, suggesting that Bax dimers may not represent the correct quaternary structure either for membrane insertion or for cytochrome c release (13). Consistent with the data reported by Gross et al. (13), our results suggest that active Bax homodimers or oligomers form following interaction with Bid. However, we cannot exclude the possibility that Bax also forms large complexes with other proteins. Both Bcl-2 and Bcl-xL were able to prevent Bax oligomerization and insertion, which is consistent with our previous results that both antiapoptotic proteins counteract the Bid-induced change of conformation of Bax by binding directly with Bax. Nevertheless, it remains possible that Bcl-xL or Bcl-2 inhibits Bax-induced cytochrome c release independently of binding to Bax (22), by forming channels which would counterbalance Bax action.

The mechanisms by which Bax, following its membrane insertion, triggers cytochrome c release from mitochondria are still unclear. It has been proposed that Bax may stimulate the opening of the permeability transition pore (PTP) through interaction with the adenine nucleotide translocator (30). As a result of PTP opening, mitochondria would swell, leading to rupture of the outer mitochondrial membrane and passive release of cytochrome c (23, 24). There are, however, types of apoptosis in which a shrinkage rather than a swelling of mitochondria has been reported (18, 27-29, 46), and in sympathetic neurons deprived of nerve growth factor, the release of cytochrome c can be reversed if caspase activation is prevented (29). Moreover, we have found that cyclosporin A, an inhibitor of the PTP, was unable to inhibit Bid-induced Bax insertion into mitochondrial membranes (results not shown) and Bax-induced cytochrome c release from mitochondria (9). Together, these studies suggest that the release of cytochrome c from mitochondria may be a well-controlled event, occurring, under certain circumstances, independently of the opening of the PTP. One possible mechanism is that Bax forms a channel large enough to allow the release of cytochrome c as well as other proteins of a similar size. The integration of Bax within membranes would be the first of a series of events leading to channel formation. Nonetheless, we report that Bax insertion into mitochondria is not sufficient to trigger cytochrome c release. Indeed, in the absence of Mg2+, cytochrome c was not released despite Bax insertion into the mitochondrial membranes.

All the experiments described above were performed with full-length Bid, which has been reported previously to translocate to mitochondria during staurosporine-induced apoptosis of HeLa cells (8). In contrast to Bax, we found that Bid does not integrate in the mitochondrial membrane. This is in contrast to what was found after cleavage of Bid by caspase 8 during interleukin-3 deprivation of FL5.12 cells. In these studies, the cleaved form of Bid (p15 BID) translocated to mitochondria and became an integral membrane protein (14). We have found that Bid cleaved by caspase 8 is at least 10-fold more efficient in triggering Bax insertion into the mitochondrial membrane and cytochrome c efflux from mitochondria (R. Eskes et al., unpublished data).

Bax integration was shown to occur in the outer mitochondrial membrane as assessed by digitonin extraction. We have not been able to detect any translocation of Bax from the outer to the inner mitochondrial membrane during the process of cytochrome c release. This contrasts with the results of others, who reported Bax redistribution from the outer to the inner mitochondrial membrane following treatment of mitochondria with atractyloside (30). Our results suggest strongly that Bax exerts its apoptotic function by being physically present in the outer mitochondrial membrane. This localization is compatible with the ability of Bax to interact with the outer mitochondrial membrane channel VDAC, as previously reported (35). This localization would also be consistent with the hypothesis that Bax itself may form a channel to allow the release of cytochrome c. Nevertheless, a fraction of Bax, as well as Bak and Bcl-xL, was found to be integrated in the outer mitochondrial membrane of mitochondria isolated from nonapoptotic cells. It is possible that in the absence of an apoptotic stimulus, both Bax and Bak are inactivated in the membrane by forming Bax-Bcl-xL or Bak-Bcl-xL heterodimers, although we cannot exclude the possibility that these proteins are also functional and play a physiological role in nonapoptotic cells.

In summary, our results are consistent with a model of cellular apoptosis in which Bid interacts with Bax to trigger a change in Bax conformation leading to dimerization (or oligomerization) and integration into the outer mitochondrial membrane (Fig. 7).


View larger version (20K):
[in this window]
[in a new window]
  		FIG. 7.   Model for the activation of Bax by Bid during apoptosis. Following an apoptotic stimulus, Bid binds to Bax and triggers a change in the conformation of Bax. As a result, Bax dimerizes (or oligomerizes) and inserts into the outer mitochondrial membrane, which results in cytochrome c (Cyt. c) release from mitochondria.


    ACKNOWLEDGMENTS

We thank S. Arkinstall and K. Maundrell for critical reading of the manuscript, C. Herbert for artwork, and T. Wells for encouraging support.

Part of this work was also supported by grants from the European Community (Biotech grant BIO4CT96 0774 to J.-C. Martinou).


    FOOTNOTES

* Corresponding author. Mailing address: Serono Pharmaceutical Research Institute, Ares Serono International S.A., 14 Chemin des Aulx, CH-1228 Plan-les Ouates, Geneva, Switzerland. Phone: 41-22-706-9822. Fax: 41-22-794-69-65. E-mail: Jean-Claude.Martinou{at}Serono.com.

dagger Present address: J. W. G.-University Frankfurt am Main, ZIM---Med Klinik III---Molekulare Hämatologie, D-60596 Frankfurt Germany.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Adams, J. M., and S. Cory. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326[Abstract/Free Full Text].
2. Antonsson, B., F. Conti, A. M. Ciavatta, S. Montessuit, S. Lewis, I. Martinou, L. Bernasconi, A. Bernard, J.-J. Mermod, G. Mazzei, K. Maundrell, F. Gambale, R. Sadoul, and J.-C. Martinou. 1997. Inhibition of Bax channel-forming activity by Bcl-2. Science 277:370-372[Abstract/Free Full Text].
3. Bossy-Wetzel, E., D. D. Newmeyer, and D. R. Green. 1998. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:37-49[CrossRef][Medline].
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248-254[CrossRef][Medline].
5. Chittenden, T., C. Flemington, A. B. Houghton, R. G. Ebb, G. J. Gallo, B. Elangovan, G. Chinnadurai, and R. J. Lutz. 1995. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14:5589-5596[Medline].
6. Chou, J. J., L. Honglin, G. S. Salvesen, J. Yuan, and G. Wagner. 1999. Solution structure of Bid, an intracellular amplifier of apoptotic signaling. Cell 96:615-624[CrossRef][Medline].
7. Deckwerth, T. L., J. L. Elliott, C. M. Knudson, E. M. J. Johnson, W. D. Snider, and S. J. Korsmeyer. 1996. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 17:401-411[CrossRef][Medline].
8. Desagher, S., A. Osen-Sand, A. Nichols, R. Eskes, S. Montessuit, S. Lauper, K. Maundrell, B. Antonsson, and J.-C. Martinou. 1999. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144:891-901[Abstract/Free Full Text].
9. Eskes, R., B. Antonsson, A. Osen-Sand, S. Montessuit, C. Richter, R. Sadoul, G. Mazzei, A. Nichols, and J.-C. Martinou. 1998. Bax-induced cytochrome C release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions. J. Cell Biol. 143:217-224[Abstract/Free Full Text].
10. Estoppey, S., I. Rodriguez, R. Sadoul, and J.-C. Martinou. 1997. Bcl-2 prevents activation of CPP32 cysteine protease and cleavage of poly (ADP-ribose) polymerase and U1-70 kD proteins in staurosporine-mediated apoptosis. Cell Death Differ. 4:34-38.
11. Goping, I. S., A. Gross, J. N. Lavoie, M. Nguyen, R. Jemmerson, K. Roth, S. J. Korsmeyer, and G. C. Shore. 1998. Regulated targeting of BAX to mitochondria. J. Cell Biol. 143:207-215[Abstract/Free Full Text].
12. Griffiths, G. J., L. Dubrez, C. P. Morgan, N. A. Jones, J. Whitehouse, B. M. Corfe, C. Dive, and J. A. Hickman. 1999. Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J. Cell Biol. 144:903-914[Abstract/Free Full Text].
13. Gross, A., J. Jockel, M. C. Wei, and S. J. Korsmeyer. 1998. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17:3878-3885[CrossRef][Medline].
14. Gross, A., X.-M. Yin, K. Wang, M. C. Wei, J. Jockel, C. Milliman, H. Erdjument-Bromage, P. Tempst, and S. J. Korsmeyer. 1999. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol. Chem. 274:1156-1163[Abstract/Free Full Text].
15. Hsu, Y.-T., K. G. Wolter, and R. J. Youle. 1997. Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis. Proc. Natl. Acad. Sci. USA 94:3668-3672[Abstract/Free Full Text].
16. Hsu, Y.-T., and R. J. Youle. 1998. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J. Biol. Chem. 273:10777-10783[Abstract/Free Full Text].
17. Jacobson, M. D. 1997. Bcl-2-related proteins get connected. Curr. Biol. 7:R277-R281[CrossRef][Medline].
18. James, T. N., F. Terasaki, E. R. Pavlovich, and A. M. Vikhert. 1993. Apoptosis and pleomorphic micromitochondriosis in the sinus nodes surgically excised from five patients with the long QT syndrome. J. Lab. Clin. Med. 122:309-323[Medline].
19. Jürgensmeier, J. M., Z. Xie, Q. Deveraux, L. Ellerby, D. Bredesen, and J. C. Reed. 1998. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95:4997-5002[Abstract/Free Full Text].
20. Kelekar, A., and C. B. Thompson. 1998. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol. 8:324-330[CrossRef][Medline].
21. Kluck, R. M., E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136[Abstract/Free Full Text].
22. Knudson, C. M., and S. J. Korsmeyer. 1997. Bcl-2 and Bax function independently to regulate cell death. Nat. Genet. 16:358-363[CrossRef][Medline].
23. Kroemer, G., B. Dallaporta, and M. Resche-Rigon. 1998. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60:619-642[CrossRef][Medline].
24. Kroemer, G., N. Zamzami, and S. A. Susin. 1997. Mitochondrial control of apoptosis. Immunol. Today 18:44-51[CrossRef][Medline].
25. Kroemer, G. C. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614-620[CrossRef][Medline].
26. Li, P., D. Nijhawan, I. Budihardjo, S. M. Srinivasula, M. Ahmad, E. S. Alnemri, and X. Wang. 1997. Cytochrome c and dATP dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489[CrossRef][Medline].
27. Lia, J., R. R. Dourmashkin, A. C. Newland, and S. M. Kelsey. 1997. Mitochondrial ultracondensation, but not swelling, is involved in TNF alpha-induced apoptosis in human T-lymphoblastic leukaemic cells. Leuk. Res. 21:973-983[CrossRef][Medline].
28. Mancini, M., B. O. Anderson, E. Caldwell, M. Sedghinasab, P. B. Paty, and D. M. Hockenbery. 1997. Mitochondrial proliferation and paradoxical membrane depolarization during terminal differenciation and apoptosis in a human colon carcinoma cell line. J. Cell Biol. 138:449-469[Abstract/Free Full Text].
29. Martinou, I., S. Desagher, R. Eskes, B. Antonsson, E. André, S. Fakan, and J.-C. Martinou. 1999. The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event. J. Cell Biol. 144:883-889[Abstract/Free Full Text].
30. Marzo, I., C. Brenner, N. Zamzami, J. M. Jürgensmeier, S. A. Susin, H. L. A. Vieira, M.-C. Prévost, Z. Xie, S. Matsuyama, J. C. Reed, and G. Kroemer. 1998. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281:2027-2031[Abstract/Free Full Text].
31. McDonnell, J. M., D. Fushman, C. L. Milliman, S. J. Korsmeyer, and D. Cowburn. 1999. Solution structure of the proapoptotic molecule Bid: a structural basis for apoptotic agonists and antagonists. Cell 96:625-634[CrossRef][Medline].
32. Miller, T. M., K. L. Moulder, C. M. Knudson, D. J. Creedon, M. Deshmukh, S. J. Korsmeyer, and E. M. J. Johnson. 1997. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J. Cell Biol. 139:205-217[Abstract/Free Full Text].
33. Minn, A. J., P. Vélez, S. L. Schendel, H. Liang, S. W. Muchmore, S. W. Fesik, M. Fill, and C. B. Thompson. 1997. Bcl-xL forms an ion channel in synthetic lipid membranes. Nature 385:353-357[CrossRef][Medline].
34. Muchmore, S. W., M. Sattler, H. Liang, R. P. Meadows, J. E. Harlan, H. S. Yoon, D. Nettesheim, B. S. Chang, C. B. Thompson, S.-L. Wong, S.-C. Ng, and S. W. Fesik. 1996. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381:335-341[CrossRef][Medline].
35. Narita, M., S. Shimizu, T. Ito, T. Chittenden, R. Lutz, H. Matsuda, and Y. Tsujimoto. 1998. Bax interacts with the prermeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA 95:14681-14686[Abstract/Free Full Text].
36. Reed, J. C. 1997. Double identity for proteins of the Bcl-2 family. Nature 387:773-776[CrossRef][Medline].
37. Rossé, T., R. Olivier, L. Monney, M. Rager, S. Conus, I. Fellay, B. Jansen, and C. Borner. 1998. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391:496-499[CrossRef][Medline].
38. Schendel, S. L., Z. Xie, M. O. Montal, S. Matsuyama, M. Montal, and J. C. Reed. 1997. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA 94:5113-5118[Abstract/Free Full Text].
39. Schlesinger, P. H., A. Gross, X.-M. Yin, K. Yamamoto, M. Saito, G. Waksman, and S. J. Korsmeyer. 1997. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl. Acad. Sci. USA 94:11357-11362[Abstract/Free Full Text].
40. Susin, S. A., N. Zamzami, M. Castedo, T. Hirsch, P. Marchetti, A. Macho, E. Daugas, M. Geuskens, and G. Kroemer. 1996. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1331-1341[Abstract/Free Full Text].
41. Vander Heiden, M. G., N. S. Chandel, E. K. Williamson, P. T. Schumacker, and C. B. Thompson. 1997. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91:627-637[CrossRef][Medline].
42. Wang, K., X.-M. Yian, D. T. Chao, C. L. Milliman, and S. J. Korsmeyer. 1996. BID: a novel BH3 domain-only death agonist. Genes Dev. 10:2859-2869[Abstract/Free Full Text].
43. Wolter, K. G., Y.-T. Hsu, C. L. Smith, A. Nechushtan, X.-G. Xi, and R. J. Youle. 1997. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139:1281-1292[Abstract/Free Full Text].
44. Yang, E., and S. J. Korsmeyer. 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88:386-401[Free Full Text].
45. Yang, J., X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T.-I. Peng, D. P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132[Abstract/Free Full Text].
46. Zhuang, J., D. Dinsdale, and G. M. Cohen. 1998. Apoptosis, in human monocytic THP.1 cells, results in the release of cytochrome c from mitochondria prior to their ultracondensation, formation of outer membrane discontinuities and reduction in inner membrane potential. Cell Death Differ. 5:953-962[CrossRef][Medline].

Molecular and Cellular Biology, February 2000, p. 929-935, Vol. 20, No. 3
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Jin, J., Mullen, T. D., Hou, Q., Bielawski, J., Bielawska, A., Zhang, X., Obeid, L. M., Hannun, Y. A., Hsu, Y.-T. (2009). AMPK inhibitor Compound C stimulates ceramide production and promotes Bax redistribution and apoptosis in MCF7 breast carcinoma cells. J. Lipid Res. 50: 2389-2397 [Abstract] [Full Text]  
  • Berger, A. K., Cortese, G. P., Amodeo, K. D., Weihofen, A., Letai, A., LaVoie, M. J. (2009). Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release. Hum Mol Genet 18: 4317-4328 [Abstract] [Full Text]  
  • Amaral, J. D., Viana, R. J. S., Ramalho, R. M., Steer, C. J., Rodrigues, C. M. P. (2009). Bile acids: regulation of apoptosis by ursodeoxycholic acid. J. Lipid Res. 50: 1721-1734 [Abstract] [Full Text]  
  • Huang, S., Okumura, K., Sinicrope, F. A. (2009). BH3 Mimetic Obatoclax Enhances TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells. Clin. Cancer Res. 15: 150-159 [Abstract] [Full Text]  
  • Hussain, A. R., Ahmed, M., Al-Jomah, N. A., Khan, A. S., Manogaran, P., Sultana, M., Abubaker, J., Platanias, L. C., Al-Kuraya, K. S., Uddin, S. (2008). Curcumin suppresses constitutive activation of nuclear factor-{kappa}B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Molecular Cancer Therapeutics 7: 3318-3329 [Abstract] [Full Text]  
  • Szabo, I., Bock, J., Grassme, H., Soddemann, M., Wilker, B., Lang, F., Zoratti, M., Gulbins, E. (2008). Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc. Natl. Acad. Sci. USA 105: 14861-14866 [Abstract] [Full Text]  
  • Jin, J., Hou, Q., Mullen, T. D., Zeidan, Y. H., Bielawski, J., Kraveka, J. M., Bielawska, A., Obeid, L. M., Hannun, Y. A., Hsu, Y.-T. (2008). Ceramide Generated by Sphingomyelin Hydrolysis and the Salvage Pathway Is Involved in Hypoxia/Reoxygenation-induced Bax Redistribution to Mitochondria in NT-2 Cells. J. Biol. Chem. 283: 26509-26517 [Abstract] [Full Text]  
  • Tokarska-Schlattner, M., Boissan, M., Munier, A., Borot, C., Mailleau, C., Speer, O., Schlattner, U., Lacombe, M.-L. (2008). The Nucleoside Diphosphate Kinase D (NM23-H4) Binds the Inner Mitochondrial Membrane with High Affinity to Cardiolipin and Couples Nucleotide Transfer with Respiration. J. Biol. Chem. 283: 26198-26207 [Abstract] [Full Text]  
  • Huang, S., Sinicrope, F. A. (2008). BH3 Mimetic ABT-737 Potentiates TRAIL-Mediated Apoptotic Signaling by Unsequestering Bim and Bak in Human Pancreatic Cancer Cells. Cancer Res. 68: 2944-2951 [Abstract] [Full Text]  
  • Reed, J. C. (2008). Bcl-2-family proteins and hematologic malignancies: history and future prospects. Blood 111: 3322-3330 [Abstract] [Full Text]  
  • Luo, W., Liu, J., Li, J., Zhang, D., Liu, M., Addo, J. K., Patil, S., Zhang, L., Yu, J., Buolamwini, J. K., Chen, J., Huang, C. (2008). Anti-cancer Effects of JKA97 Are Associated with Its Induction of Cell Apoptosis via a Bax-dependent and p53-independent Pathway. J. Biol. Chem. 283: 8624-8633 [Abstract] [Full Text]  
  • Nelson, M. M., Jones, A. R., Carmen, J. C., Sinai, A. P., Burchmore, R., Wastling, J. M. (2008). Modulation of the Host Cell Proteome by the Intracellular Apicomplexan Parasite Toxoplasma gondii. Infect. Immun. 76: 828-844 [Abstract] [Full Text]  
  • Halder, B., Bhattacharya, U., Mukhopadhyay, S., Giri, A. K. (2008). Molecular mechanism of black tea polyphenols induced apoptosis in human skin cancer cells: involvement of Bax translocation and mitochondria mediated death cascade. Carcinogenesis 29: 129-138 [Abstract] [Full Text]  
  • Steckley, D., Karajgikar, M., Dale, L. B., Fuerth, B., Swan, P., Drummond-Main, C., Poulter, M. O., Ferguson, S. S. G., Strasser, A., Cregan, S. P. (2007). Puma Is a Dominant Regulator of Oxidative Stress Induced Bax Activation and Neuronal Apoptosis. J. Neurosci. 27: 12989-12999 [Abstract] [Full Text]  
  • Meslin, F., Hamai, A., Gao, P., Jalil, A., Cahuzac, N., Chouaib, S., Mehrpour, M. (2007). Silencing of Prion Protein Sensitizes Breast Adriamycin-Resistant Carcinoma Cells to TRAIL-Mediated Cell Death. Cancer Res. 67: 10910-10919 [Abstract] [Full Text]  
  • Kang, M. H., Kang, Y. H., Szymanska, B., Wilczynska-Kalak, U., Sheard, M. A., Harned, T. M., Lock, R. B., Reynolds, C. P. (2007). Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo. Blood 110: 2057-2066 [Abstract] [Full Text]  
  • Er, E., Lalier, L., Cartron, P.-F., Oliver, L., Vallette, F. M. (2007). Control of Bax Homodimerization by Its Carboxyl Terminus. J. Biol. Chem. 282: 24938-24947 [Abstract] [Full Text]  
  • Weber, A., Paschen, S. A., Heger, K., Wilfling, F., Frankenberg, T., Bauerschmitt, H., Seiffert, B. M., Kirschnek, S., Wagner, H., Hacker, G. (2007). BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins. JCB 177: 625-636 [Abstract] [Full Text]  
  • Blomgran, R., Zheng, L., Stendahl, O. (2007). Cathepsin-cleaved Bid promotes apoptosis in human neutrophils via oxidative stress-induced lysosomal membrane permeabilization. J. Leukoc. Biol. 81: 1213-1223 [Abstract] [Full Text]  
  • Aoudjehane, L., Podevin, P., Scatton, O., Jaffray, P., Dusanter-Fourt, I., Feldmann, G., Massault, P.-P., Grira, L., Bringuier, A., Dousset, B., Chouzenoux, S., Soubrane, O., Calmus, Y., Conti, F. (2007). Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway. FASEB J. 21: 1433-1444 [Abstract] [Full Text]  
  • Hussain, A. R., Al-Jomah, N. A., Siraj, A. K., Manogaran, P., Al-Hussein, K., Abubaker, J., Platanias, L. C., Al-Kuraya, K. S., Uddin, S. (2007). Sanguinarine-Dependent Induction of Apoptosis in Primary Effusion Lymphoma Cells. Cancer Res. 67: 3888-3897 [Abstract] [Full Text]  
  • Del Re, D. P., Miyamoto, S., Brown, J. H. (2007). RhoA/Rho Kinase Up-regulate Bax to Activate a Mitochondrial Death Pathway and Induce Cardiomyocyte Apoptosis. J. Biol. Chem. 282: 8069-8078 [Abstract] [Full Text]  
  • Chin, T.-Y., Lin, H.-C., Kuo, J.-P., Chueh, S.-H. (2007). Dual effect of thapsigargin on cell death in porcine aortic smooth muscle cells. Am. J. Physiol. Cell Physiol. 292: C383-C395 [Abstract] [Full Text]  
  • Taylor, J. M., Quilty, D., Banadyga, L., Barry, M. (2006). The Vaccinia Virus Protein F1L Interacts with Bim and Inhibits Activation of the Pro-apoptotic Protein Bax. J. Biol. Chem. 281: 39728-39739 [Abstract] [Full Text]  
  • Oh, K. J., Barbuto, S., Pitter, K., Morash, J., Walensky, L. D., Korsmeyer, S. J. (2006). A Membrane-targeted BID BCL-2 Homology 3 Peptide Is Sufficient for High Potency Activation of BAX in Vitro. J. Biol. Chem. 281: 36999-37008 [Abstract] [Full Text]  
  • Ying, S., Fischer, S. F., Pettengill, M., Conte, D., Paschen, S. A., Ojcius, D. M., Hacker, G. (2006). Characterization of Host Cell Death Induced by Chlamydia trachomatis. Infect. Immun. 74: 6057-6066 [Abstract] [Full Text]  
  • Tomiyama, A., Serizawa, S., Tachibana, K., Sakurada, K., Samejima, H., Kuchino, Y., Kitanaka, C. (2006). Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors bax and bak.. JNCI J Natl Cancer Inst 98: 1462-1473 [Abstract] [Full Text]  
  • Parone, P. A., James, D. I., Da Cruz, S., Mattenberger, Y., Donze, O., Barja, F., Martinou, J.-C. (2006). Inhibiting the mitochondrial fission machinery does not prevent bax/bak-dependent apoptosis.. Mol. Cell. Biol. 26: 7397-7408 [Abstract] [Full Text]  
  • Xin, M., Deng, X. (2006). Protein Phosphatase 2A Enhances the Proapoptotic Function of Bax through Dephosphorylation. J. Biol. Chem. 281: 18859-18867 [Abstract] [Full Text]  
  • Yun, J.-M., Kweon, M.-H., Kwon, H., Hwang, J.-K., Mukhtar, H. (2006). Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145. Carcinogenesis 27: 1454-1464 [Abstract] [Full Text]  
  • Tan, C., Dlugosz, P. J., Peng, J., Zhang, Z., Lapolla, S. M., Plafker, S. M., Andrews, D. W., Lin, J. (2006). Auto-activation of the Apoptosis Protein Bax Increases Mitochondrial Membrane Permeability and Is Inhibited by Bcl-2. J. Biol. Chem. 281: 14764-14775 [Abstract] [Full Text]  
  • Han, J., Goldstein, L. A., Gastman, B. R., Rabinowich, H. (2006). Interrelated Roles for Mcl-1 and BIM in Regulation of TRAIL-mediated Mitochondrial Apoptosis. J. Biol. Chem. 281: 10153-10163 [Abstract] [Full Text]  
  • Clohessy, J. G., Zhuang, J., de Boer, J., Gil-Gomez, G., Brady, H. J. M. (2006). Mcl-1 Interacts with Truncated Bid and Inhibits Its Induction of Cytochrome c Release and Its Role in Receptor-mediated Apoptosis. J. Biol. Chem. 281: 5750-5759 [Abstract] [Full Text]  
  • Ward, M. W., Rehm, M., Duessmann, H., Kacmar, S., Concannon, C. G., Prehn, J. H. M. (2006). Real Time Single Cell Analysis of Bid Cleavage and Bid Translocation during Caspase-dependent and Neuronal Caspase-independent Apoptosis. J. Biol. Chem. 281: 5837-5844 [Abstract] [Full Text]  
  • Hetz, C., Vitte, P.-A., Bombrun, A., Rostovtseva, T. K., Montessuit, S., Hiver, A., Schwarz, M. K., Church, D. J., Korsmeyer, S. J., Martinou, J.-C., Antonsson, B. (2005). Bax Channel Inhibitors Prevent Mitochondrion-mediated Apoptosis and Protect Neurons in a Model of Global Brain Ischemia. J. Biol. Chem. 280: 42960-42970 [Abstract] [Full Text]  
  • Pagliari, L. J., Kuwana, T., Bonzon, C., Newmeyer, D. D., Tu, S., Beere, H. M., Green, D. R. (2005). The multidomain proapoptotic molecules Bax and Bak are directly activated by heat. Proc. Natl. Acad. Sci. USA 102: 17975-17980 [Abstract] [Full Text]  
  • Wasilenko, S. T., Banadyga, L., Bond, D., Barry, M. (2005). The Vaccinia Virus F1L Protein Interacts with the Proapoptotic Protein Bak and Inhibits Bak Activation. J. Virol. 79: 14031-14043 [Abstract] [Full Text]  
  • Takahashi, Y., Karbowski, M., Yamaguchi, H., Kazi, A., Wu, J., Sebti, S. M., Youle, R. J., Wang, H.-G. (2005). Loss of Bif-1 Suppresses Bax/Bak Conformational Change and Mitochondrial Apoptosis. Mol. Cell. Biol. 25: 9369-9382 [Abstract] [Full Text]  
  • Tan, K. O., Fu, N. Y., Sukumaran, S. K., Chan, S.-L., Kang, J. H., Poon, K. L., Chen, B. S., Yu, V. C. (2005). MAP-1 is a mitochondrial effector of Bax. Proc. Natl. Acad. Sci. USA 102: 14623-14628 [Abstract] [Full Text]  
  • Redlak, M. J., Power, J. J., Miller, T. A. (2005). Role of mitochondria in aspirin-induced apoptosis in human gastric epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G731-G738 [Abstract] [Full Text]  
  • Li, D. W.-C., Liu, J.-P., Mao, Y.-W., Xiang, H., Wang, J., Ma, W.-Y., Dong, Z., Pike, H. M., Brown, R. E., Reed, J. C. (2005). Calcium-activated RAF/MEK/ERK Signaling Pathway Mediates p53-dependent Apoptosis and Is Abrogated by {alpha}B-Crystallin through Inhibition of RAS Activation. Mol. Biol. Cell 16: 4437-4453 [Abstract] [Full Text]  
  • Lee, S.-Y., Cherla, R. P., Caliskan, I., Tesh, V. L. (2005). Shiga Toxin 1 Induces Apoptosis in the Human Myelogenous Leukemia Cell Line THP-1 by a Caspase-8-Dependent, Tumor Necrosis Factor Receptor-Independent Mechanism. Infect. Immun. 73: 5115-5126 [Abstract] [Full Text]  
  • Grinberg, M., Schwarz, M., Zaltsman, Y., Eini, T., Niv, H., Pietrokovski, S., Gross, A. (2005). Mitochondrial Carrier Homolog 2 Is a Target of tBID in Cells Signaled To Die by Tumor Necrosis Factor Alpha. Mol. Cell. Biol. 25: 4579-4590 [Abstract] [Full Text]  
  • Darios, F., Muriel, M.-P., Khondiker, M. E., Brice, A., Ruberg, M. (2005). Neurotoxic Calcium Transfer from Endoplasmic Reticulum to Mitochondria Is Regulated by Cyclin-Dependent Kinase 5-Dependent Phosphorylation of Tau. J. Neurosci. 25: 4159-4168 [Abstract] [Full Text]  
  • Broaddus, V. C., Dansen, T. B., Abayasiriwardana, K. S., Wilson, S. M., Finch, A. J., Swigart, L. B., Hunt, A. E., Evan, G. I. (2005). Bid Mediates Apoptotic Synergy between Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) and DNA Damage. J. Biol. Chem. 280: 12486-12493 [Abstract] [Full Text]  
  • Cartron, P.-F., Arokium, H., Oliver, L., Meflah, K., Manon, S., Vallette, F. M. (2005). Distinct Domains Control the Addressing and the Insertion of Bax into Mitochondria. J. Biol. Chem. 280: 10587-10598 [Abstract] [Full Text]  
  • Liu, Y., Yerushalmi, G. M., Grigera, P. R., Parsons, J. T. (2005). Mislocalization or Reduced Expression of Arf GTPase-activating Protein ASAP1 Inhibits Cell Spreading and Migration by Influencing Arf1 GTPase Cycling. J. Biol. Chem. 280: 8884-8892 [Abstract] [Full Text]  
  • Clemons, N. J., Buzzard, K., Steel, R., Anderson, R. L. (2005). Hsp72 Inhibits Fas-mediated Apoptosis Upstream of the Mitochondria in Type II Cells. J. Biol. Chem. 280: 9005-9012 [Abstract] [Full Text]  
  • Klee, M., Pimentel-Muinos, F. X. (2005). Bcl-XL specifically activates Bak to induce swelling and restructuring of the endoplasmic reticulum. JCB 168: 723-734 [Abstract] [Full Text]  
  • Lucken-Ardjomande, S., Martinou, J.-C. (2005). Newcomers in the process of mitochondrial permeabilization. J. Cell Sci. 118: 473-483 [Abstract] [Full Text]  
  • Li, H., Telemaque, S., Miller, R. E., Marsh, J. D. (2005). High Glucose Inhibits Apoptosis Induced by Serum Deprivation in Vascular Smooth Muscle Cells via Upregulation of Bcl-2 and Bcl-xl. Diabetes 54: 540-545 [Abstract] [Full Text]  
  • Lai, J. C., Benimetskaya, L., Khvorova, A., Wu, S., Hua, E., Miller, P., Stein, C.A. (2005). Phosphorothioate oligodeoxynucleotides and G3139 induce apoptosis in 518A2 melanoma cells. Molecular Cancer Therapeutics 4: 305-315 [Abstract] [Full Text]  
  • Oh, K. J., Barbuto, S., Meyer, N., Kim, R.-S., Collier, R. J., Korsmeyer, S. J. (2005). Conformational Changes in BID, a Pro-apoptotic BCL-2 Family Member, upon Membrane Binding: A SITE-DIRECTED SPIN LABELING STUDY. J. Biol. Chem. 280: 753-767 [Abstract] [Full Text]  
  • Tourian, L. Jr, Zhao, H., Srikant, C. B. (2004). p38{alpha}, but not p38{beta}, inhibits the phosphorylation and presence of c-FLIPS in DISC to potentiate Fas-mediated caspase-8 activation and type I apoptotic signaling. J. Cell Sci. 117: 6459-6471 [Abstract] [Full Text]  
  • WANG, X., ZHANG, J., KIM, H. P., WANG, Y., CHOI, A. M. K., RYTER, S. W. (2004). Bcl-XL disrupts death-inducing signal complex formation in plasma membrane induced by hypoxia/reoxygenation. FASEB J. 18: 1826-1833 [Abstract] [Full Text]  
  • Crow, M. T., Mani, K., Nam, Y.-J., Kitsis, R. N. (2004). The Mitochondrial Death Pathway and Cardiac Myocyte Apoptosis. Circ. Res. 95: 957-970 [Abstract] [Full Text]  
  • Guihard, G., Bellot, G., Moreau, C., Pradal, G., Ferry, N., Thomy, R., Fichet, P., Meflah, K., Vallette, F. M. (2004). The Mitochondrial Apoptosis-induced Channel (MAC) Corresponds to a Late Apoptotic Event. J. Biol. Chem. 279: 46542-46550 [Abstract] [Full Text]  
  • Cho, D.-H., Hong, Y.-M., Lee, H.-J., Woo, H.-N., Pyo, J.-O., Mak, T. W., Jung, Y.-K. (2004). Induced Inhibition of Ischemic/Hypoxic Injury by APIP, a Novel Apaf-1-interacting Protein. J. Biol. Chem. 279: 39942-39950 [Abstract] [Full Text]  
  • Forger, N. G., Rosen, G. J., Waters, E. M., Jacob, D., Simerly, R. B., de Vries, G. J. (2004). Deletion of Bax eliminates sex differences in the mouse forebrain. Proc. Natl. Acad. Sci. USA 101: 13666-13671 [Abstract] [Full Text]  
  • Adachi, M., Higuchi, H., Miura, S., Azuma, T., Inokuchi, S., Saito, H., Kato, S., Ishii, H. (2004). Bax interacts with the voltage-dependent anion channel and mediates ethanol-induced apoptosis in rat hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G695-G705 [Abstract] [Full Text]  
  • Zhang, L., Shimizu, S., Sakamaki, K., Yonehara, S., Tsujimoto, Y. (2004). A Caspase-8-independent Signaling Pathway Activated by Fas Ligation Leads to Exposure of the Bak N Terminus. J. Biol. Chem. 279: 33865-33874 [Abstract] [Full Text]  
  • Valentijn, A. J., Gilmore, A. P. (2004). Translocation of Full-length Bid to Mitochondria during Anoikis. J. Biol. Chem. 279: 32848-32857 [Abstract] [Full Text]  
  • Terrones, O., Antonsson, B., Yamaguchi, H., Wang, H.-G., Liu, J., Lee, R. M., Herrmann, A., Basanez, G. (2004). Lipidic Pore Formation by the Concerted Action of Proapoptotic BAX and tBID. J. Biol. Chem. 279: 30081-30091 [Abstract] [Full Text]  
  • Gong, X.-M., Choi, J., Franzin, C. M., Zhai, D., Reed, J. C., Marassi, F. M. (2004). Conformation of Membrane-associated Proapoptotic tBid. J. Biol. Chem. 279: 28954-28960 [Abstract] [Full Text]  
  • Kim, T.-H., Zhao, Y., Ding, W.-X., Shin, J. N., He, X., Seo, Y.-W., Chen, J., Rabinowich, H., Amoscato, A. A., Yin, X.-M. (2004). Bid-Cardiolipin Interaction at Mitochondrial Contact Site Contributes to Mitochondrial Cristae Reorganization and Cytochrome c Release. Mol. Biol. Cell 15: 3061-3072 [Abstract] [Full Text]  
  • Maianski, N. A., Roos, D., Kuijpers, T. W. (2004). Bid Truncation, Bid/Bax Targeting to the Mitochondria, and Caspase Activation Associated with Neutrophil Apoptosis Are Inhibited by Granulocyte Colony-Stimulating Factor. J. Immunol. 172: 7024-7030 [Abstract] [Full Text]  
  • Arnoult, D., Bartle, L. M., Skaletskaya, A., Poncet, D., Zamzami, N., Park, P. U., Sharpe, J., Youle, R. J., Goldmacher, V. S. (2004). Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. Proc. Natl. Acad. Sci. USA 101: 7988-7993 [Abstract] [Full Text]  
  • Poncet, D., Larochette, N., Pauleau, A.-L., Boya, P., Jalil, A.-A., Cartron, P.-F., Vallette, F., Schnebelen, C., Bartle, L. M., Skaletskaya, A., Boutolleau, D., Martinou, J.-C., Goldmacher, V. S., Kroemer, G., Zamzami, N. (2004). An Anti-apoptotic Viral Protein That Recruits Bax to Mitochondria. J. Biol. Chem. 279: 22605-22614 [Abstract] [Full Text]  
  • Rostovtseva, T. K., Antonsson, B., Suzuki, M., Youle, R. J., Colombini, M., Bezrukov, S. M. (2004). Bid, but Not Bax, Regulates VDAC Channels. J. Biol. Chem. 279: 13575-13583 [Abstract] [Full Text]  
  • Erler, J. T., Cawthorne, C. J., Williams, K. J., Koritzinsky, M., Wouters, B. G., Wilson, C., Miller, C., Demonacos, C., Stratford, I. J., Dive, C. (2004). Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug Resistance. Mol. Cell. Biol. 24: 2875-2889 [Abstract] [Full Text]  
  • Hagg, M., Berndtsson, M., Mandic, A., Zhou, R., Shoshan, M. C., Linder, S. (2004). Induction of endoplasmic reticulum stress by ellipticine plant alkaloids. Molecular Cancer Therapeutics 3: 489-497 [Abstract] [Full Text]  
  • Schinzel, A., Kaufmann, T., Schuler, M., Martinalbo, J., Grubb, D., Borner, C. (2004). Conformational control of Bax localization and apoptotic activity by Pro168. JCB 164: 1021-1032 [Abstract] [Full Text]  
  • Lee, Y. J., Froelich, C. J., Fujita, N., Tsuruo, T., Kim, J. H. (2004). Reconstitution of Caspase-3 Confers Low Glucose-Enhanced Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Cytotoxicity and Akt Cleavage. Clin. Cancer Res. 10: 1894-1900 [Abstract] [Full Text]  
  • Weng, Y.-P., Lin, Y.-P., Hsu, C.-I., Lin, J.-Y. (2004). Functional Domains of a Pore-forming Cardiotoxic Protein, Volvatoxin A2. J. Biol. Chem. 279: 6805-6814 [Abstract] [Full Text]  
  • Hur, Y.-G., Yun, Y., Won, J. (2004). Rosmarinic Acid Induces p56lck-Dependent Apoptosis in Jurkat and Peripheral T Cells via Mitochondrial Pathway Independent from Fas/Fas Ligand Interaction. J. Immunol. 172: 79-87 [Abstract] [Full Text]  
  • Yethon, J. A., Epand, R. F., Leber, B., Epand, R. M., Andrews, D. W. (2003). Interaction with a Membrane Surface Triggers a Reversible Conformational Change in Bax Normally Associated with Induction of Apoptosis. J. Biol. Chem. 278: 48935-48941 [Abstract] [Full Text]  
  • Heerdt, B. G., Houston, M. A., Wilson, A. J., Augenlicht, L. H. (2003). The Intrinsic Mitochondrial Membrane Potential ({Delta}{psi}m) Is Associated with Steady-State Mitochondrial Activity and the Extent to Which Colonic Epithelial Cells Undergo Butyrate-mediated Growth Arrest and Apoptosis. Cancer Res. 63: 6311-6319 [Abstract] [Full Text]  
  • Cao, X., Deng, X., May, W. S. (2003). Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood 102: 2605-2614 [Abstract] [Full Text]  
  • Pervin, S., Singh, R., Chaudhuri, G. (2003). Nitric-Oxide-induced Bax Integration into the Mitochondrial Membrane Commits MDA-MB-468 Cells to Apoptosis: Essential Role of Akt. Cancer Res. 63: 5470-5479 [Abstract] [Full Text]  
  • Shou, Y., Li, L., Prabhakaran, K., Borowitz, J. L., Isom, G. E. (2003). p38 Mitogen-Activated Protein Kinase Regulates Bax Translocation in Cyanide-Induced Apoptosis. Toxicol Sci 75: 99-107 [Abstract] [Full Text]  
  • Valentijn, A. J., Metcalfe, A. D., Kott, J., Streuli, C. H., Gilmore, A. P. (2003). Spatial and temporal changes in Bax subcellular localization during anoikis. JCB 162: 599-612 [Abstract] [Full Text]  
  • Cotteret, S., Jaffer, Z. M., Beeser, A., Chernoff, J. (2003). p21-Activated Kinase 5 (Pak5) Localizes to Mitochondria and Inhibits Apoptosis by Phosphorylating BAD. Mol. Cell. Biol. 23: 5526-5539 [Abstract] [Full Text]  
  • Bidere, N., Lorenzo, H. K., Carmona, S., Laforge, M., Harper, F., Dumont, C., Senik, A. (2003). Cathepsin D Triggers Bax Activation, Resulting in Selective Apoptosis-inducing Factor (AIF) Relocation in T Lymphocytes Entering the Early Commitment Phase to Apoptosis. J. Biol. Chem. 278: 31401-31411 [Abstract] [Full Text]  
  • Ray, S., Almasan, A. (2003). Apoptosis Induction in Prostate Cancer Cells and Xenografts by Combined Treatment with Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand and CPT-11. Cancer Res. 63: 4713-4723 [Abstract] [Full Text]  
  • Gupta, S., Yel, L., Kim, D., Kim, C., Chiplunkar, S., Gollapudi, S. (2003). Arsenic Trioxide Induces Apoptosis in Peripheral Blood T Lymphocyte Subsets by Inducing Oxidative Stress: A Role of Bcl-2. Molecular Cancer Therapeutics 2: 711-719 [Abstract] [Full Text]  
  • Wang, X., Ryter, S. W., Dai, C., Tang, Z.-L., Watkins, S. C., Yin, X.-M., Song, R., Choi, A. M. K. (2003). Necrotic Cell Death in Response to Oxidant Stress Involves the Activation of the Apoptogenic Caspase-8/Bid Pathway. J. Biol. Chem. 278: 29184-29191 [Abstract] [Full Text]  
  • Ethier, C., Raymond, V.-A., Musallam, L., Houle, R., Bilodeau, M. (2003). Antiapoptotic effect of EGF on mouse hepatocytes associated with downregulation of proapoptotic Bid protein. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G298-G308 [Abstract] [Full Text]  
  • Cartron, P.-F., Juin, P., Oliver, L., Martin, S., Meflah, K., Vallette, F. M. (2003). Nonredundant Role of Bax and Bak in Bid-Mediated Apoptosis. Mol. Cell. Biol. 23: 4701-4712 [Abstract] [Full Text]  
  • Gao, C., Sun, W., Christofidou-Solomidou, M., Sawada, M., Newman, D. K., Bergom, C., Albelda, S. M., Matsuyama, S., Newman, P. J. (2003). PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood 102: 169-179 [Abstract] [Full Text]  
  • Ruffolo, S. C., Shore, G. C. (2003). BCL-2 Selectively Interacts with the BID-induced Open Conformer of BAK, Inhibiting BAK Auto-oligomerization. J. Biol. Chem. 278: 25039-25045 [Abstract] [Full Text]  
  • Kasibhatla, S., Tseng, B. (2003). Why Target Apoptosis in Cancer Treatment?. Molecular Cancer Therapeutics 2: 573-580 [Abstract] [Full Text]  
  • Moreau, C., Cartron, P.-F., Hunt, A., Meflah, K., Green, D. R., Evan, G., Vallette, F. M., Juin, P. (2003). Minimal BH3 Peptides Promote Cell Death by Antagonizing Anti-apoptotic Proteins. J. Biol. Chem. 278: 19426-19435 [Abstract] [Full Text]  
  • Wang, P., Valentijn, A. J., Gilmore, A. P., Streuli, C. H. (2003). Early Events in the Anoikis Program Occur in the Absence of Caspase Activation. J. Biol. Chem. 278: 19917-19925 [Abstract] [Full Text]  
  • Yi, X., Yin, X.-M., Dong, Z. (2003). Inhibition of Bid-induced Apoptosis by Bcl-2. tBid INSERTION, Bax TRANSLOCATION, AND Bax/Bak OLIGOMERIZATION SUPPRESSED. J. Biol. Chem. 278: 16992-16999 [Abstract] [Full Text]  
  • Esposti, M. D., Ferry, G., Masdehors, P., Boutin, J. A., Hickman, J. A., Dive, C. (2003). Post-translational Modification of Bid Has Differential Effects on Its Susceptibility to Cleavage by Caspase 8 or Caspase 3. J. Biol. Chem. 278: 15749-15757 [Abstract] [Full Text]  
  • Pratt, M.A. C., Niu, M.-Y. (2003). Bcl-2 Controls Caspase Activation Following a p53-dependent Cyclin D1-induced Death Signal. J. Biol. Chem. 278: 14219-14229 [Abstract] [Full Text]  
  • Wang, B., Nguyen, M., Breckenridge, D. G., Stojanovic, M., Clemons, P. A., Kuppig, S., Shore, G. C. (2003). Uncleaved BAP31 in Association with A4 Protein at the Endoplasmic Reticulum Is an Inhibitor of Fas-initiated Release of Cytochrome c from Mitochondria. J. Biol. Chem. 278: 14461-14468 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eskes, R.
Right arrow Articles by Martinou, J.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eskes, R.
Right arrow Articles by Martinou, J.-C.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»